Strategic appointments advance Addgene’s growth and market expansion strategy
WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) — Addgene, an organization empowering discovery by providing scientists with a vast catalog of expertly curated and quality-controlled plasmids, viral vectors, and recombinant antibodies, today announced the expansion of its management team and Board of Directors with numerous industry leaders. These key appointments support Addgene’s growth strategy and illustrate its responsiveness to the evolving needs of the life sciences community.
“Addgene is thrilled to have the expertise of this group of leaders in life sciences and technology as part of our management team and Board of Directors – a testament to the value of our vision for a globally connected scientific community,” said Chonnettia Jones, PhD, President and Executive Director at Addgene. “They will be invaluable as we continue to expand our trusted approach, offering tools that ease research for a wider audience, from plasmids for scientists engaging in curiosity-driven discovery to customizable reagents for industry innovators.”
Management Appointments
Board Appointments
“At a time when the support for scientific research has never been more important, I’m thrilled to serve as Board Chair of Addgene, which has been empowering scientists to advance discoveries and biological breakthroughs for more than two decades,” said Luk H. Vandenberghe, PhD, Board Chair of Addgene. “I look forward to my continued collaboration with Addgene’s visionary team as we explore new ways to improve access to high-quality research materials across the globe.”
About Addgene
Addgene is a purpose-driven organization committed to accelerating discovery and innovation by helping scientists conduct experiments with greater ease, speed and reproducibility. We are pioneers in scientific sharing, providing a vast catalog of expertly curated and quality-controlled plasmids developed by researchers around the world. We offer viral vector and recombinant antibody services built from the same trusted approach. Our dedicated team reduces barriers to scientific progress by facilitating material transfers and providing world-class educational resources. At Addgene, we care about building a globally connected scientific community, collaborating and sharing seamlessly to unlock the full potential of research. For more information, visit https://www.addgene.org.
Media Contact:
Michael Falcone
Pearl Street Partners
michael@pearlst.com
(617) 990-6712
– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…
Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…
ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…